Treatment for Type 2E Limb Girdle Muscular Dystrophy Gets Rare Pediatric Drug Designation
According to a story from Business Wire, the gene therapy company Myonexus Therapeutics announced that the U.S. FDA has given Rare Pediatric Disease Designation for its gene therapy candidate MYO-101.…
 
								 
								 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
															 
            